Physician profile
Eman Soultan
NPI 1922270925
$686.49
in general payments reported to CMS, 2019-2025
6 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.01 · 2022: $75.44 · 2023: $241 · 2024: $194 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555 · Education: $35.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.42 |
| Education | $35.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $284.67 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $192.09 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $85.04 | 2025 | Veozah |
| Myovant Sciences INC. | $75.44 | 2022 | |
| Pfizer INC. | $29.24 | 2024 | |
| Roche Diagnostics Corporation | $20.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eman Soultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.